Breaking

Five Covid-19 Patients in Arua Referred to Gulu over Insufficient Oxygen Supply

According to Dr Apangu, the production and supply of oxygen remain low coupled with intermittent power challenges at the hospital necessitating the referral of some of the critical patients to Gulu regional hospital.
Members of Arua City Covid19 Taskforce during a review meeting

Audio 3

Arua Regional Referral Hospital has referred five covid-19 patients to Gulu referral hospital over insufficient oxygen supply.

Dr Pontius Apangu the Principal Health officer Arua City and Secretary to the City Covid19 Taskforce says the five are part of the 14 patients who were admitted last weekend at the hospital’s Covid-19 Treatment Unit. The five were referred on Friday.

According to Dr Apangu, the production and supply of oxygen remain low coupled with intermittent power challenges at the hospital necessitating the referral of some of the critical patients to Gulu regional hospital.

  // Cue in; They noted the breakdown…

Cue out; the status quo is still not good. //

Martin Oroch the Resident City Commissioner Arua and chairman of City Covid19 taskforce says that referring patients from Arua to Gulu is unrealistic. He adds that challenges of Oxygen and power supply should be resolved with immediate effect. 

 // Cue in; A referral hospital referring…

Cue out; two regional referral hospitals. //

 Dr Gilbert Aniku the acting Arua Hospital Director and in charge of Covid19 Treatment Unit said the hospital needs an additional Oxygen plant to manage the current needs.

According to Dr Aniku, many Covid19 patients first seek treatment in private facilities and when their condition deteriorates, they are rushed to the referral hospital making it difficult to manage them.  

// Cue in; It still needs to be repaired…

Cue out; do any magic at that stage.//

Records from the Surveillance and Biostatistics department at the treatment Unit indicate that 6 people succumbed to Covid19 this week at Arua hospital and the positivity rate stands at 11.6 percent with most of the patients under home-based care treatment. .